Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. [electronic resource]
Producer: 20181003Description: 626-633 p. digitalISSN:- 1875-2128
- Aged
- Area Under Curve
- Aspirin -- adverse effects
- Blood Platelets -- drug effects
- Chi-Square Distribution
- Clopidogrel
- Coronary Angiography
- Coronary Circulation
- Drug Resistance
- Female
- Humans
- Male
- Microcirculation
- Middle Aged
- Multivariate Analysis
- No-Reflow Phenomenon -- diagnostic imaging
- Odds Ratio
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Function Tests
- Predictive Value of Tests
- Prospective Studies
- Purinergic P2Y Receptor Antagonists -- adverse effects
- ROC Curve
- Receptors, Purinergic P2Y12 -- blood
- Risk Factors
- ST Elevation Myocardial Infarction -- blood
- Ticlopidine -- adverse effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.